NCT05440786 2026-04-13CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's SarcomaEli Lilly and CompanyPhase 2 Active not recruiting46 enrolled 19 charts
NCT02846987 2025-06-05Study of Abemaciclib in Dedifferentiated LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting33 enrolled